These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 9721233)

  • 1. Heterologous protection of mice from a lethal human H1N1 influenza A virus infection by H3N8 equine defective interfering virus: comparison of defective RNA sequences isolated from the DI inoculum and mouse lung.
    Duhaut SD; Dimmock NJ
    Virology; 1998 Sep; 248(2):241-53. PubMed ID: 9721233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of putative defective interfering (DI) A/WSN RNAs isolated from the lungs of mice protected from an otherwise lethal respiratory infection with influenza virus A/WSN (H1N1): a subset of the inoculum DI RNAs.
    Noble S; Dimmock NJ
    Virology; 1995 Jun; 210(1):9-19. PubMed ID: 7793084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective interfering type A equine influenza virus (H3N8) protects mice from morbidity and mortality caused by homologous and heterologous subtypes of influenza A virus.
    Noble S; Dimmock NJ
    J Gen Virol; 1994 Dec; 75 ( Pt 12)():3485-91. PubMed ID: 7996140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interfering vaccine (defective interfering influenza A virus) protects ferrets from influenza, and allows them to develop solid immunity to reinfection.
    Mann A; Marriott AC; Balasingam S; Lambkin R; Oxford JS; Dimmock NJ
    Vaccine; 2006 May; 24(20):4290-6. PubMed ID: 16621180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interfering vaccine: a novel antiviral that converts a potentially virulent infection into one that is subclinical and immunizing.
    Noble S; McLain L; Dimmock NJ
    Vaccine; 2004 Aug; 22(23-24):3018-25. PubMed ID: 15297051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approximately 150 nucleotides from the 5' end of an influenza A segment 1 defective virion RNA are needed for genome stability during passage of defective virus in infected cells.
    Duhaut S; Dimmock NJ
    Virology; 2000 Sep; 275(2):278-85. PubMed ID: 10998328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of mice from lethal influenza: evidence that defective interfering virus modulates the immune response and not virus multiplication.
    Dimmock NJ; Beck S; McLain L
    J Gen Virol; 1986 May; 67 ( Pt 5)():839-50. PubMed ID: 2422317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective influenza A virus generated entirely from plasmids: its RNA is expressed in infected mouse lung and modulates disease.
    Duhaut SD; Dimmock NJ
    J Virol Methods; 2003 Mar; 108(1):75-82. PubMed ID: 12565156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of three strains of mice against lethal influenza in vivo by defective interfering virus.
    Morgan DJ; McLain L; Dimmock NJ
    Virus Res; 1993 Aug; 29(2):179-83. PubMed ID: 8212859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of mice from lethal influenza by adoptive transfer of non-neutralizing haemagglutination-inhibiting IgG obtained from the lungs of infected animals treated with defective interfering virus.
    McLain L; Dimmock NJ
    J Gen Virol; 1989 Oct; 70 ( Pt 10)():2615-24. PubMed ID: 2794973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A live attenuated H1N1 M1 mutant provides broad cross-protection against influenza A viruses, including highly pathogenic A/Vietnam/1203/2004, in mice.
    Xie H; Liu TM; Lu X; Wu Z; Belser JA; Katz JM; Tumpey TM; Ye Z
    J Infect Dis; 2009 Dec; 200(12):1874-83. PubMed ID: 19909080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The genomic sequence of defective interfering Semliki Forest virus (SFV) determines its ability to be replicated in mouse brain and to protect against a lethal SFV infection in vivo.
    Thomson M; White CL; Dimmock NJ
    Virology; 1998 Feb; 241(2):215-23. PubMed ID: 9499796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Toscana virus-defective interfering particles generated in vivo.
    Marchi A; Nicoletti L; Accardi L; Di Bonito P; Giorgi C
    Virology; 1998 Jun; 246(1):125-33. PubMed ID: 9657000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of mice from lethal influenza by defective interfering virus: T cell responses.
    McLain L; Morgan DJ; Dimmock NJ
    J Gen Virol; 1992 Feb; 73 ( Pt 2)():375-81. PubMed ID: 1371542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective small interfering RNAs targeting matrix and nucleocapsid protein gene inhibit influenza A virus replication in cells and mice.
    Zhou H; Jin M; Yu Z; Xu X; Peng Y; Wu H; Liu J; Liu H; Cao S; Chen H
    Antiviral Res; 2007 Nov; 76(2):186-93. PubMed ID: 17719657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo generation and accumulation of tomato bushy stunt virus defective interfering RNAs without serial host passage.
    Law MD; Morris TJ
    Virology; 1994 Jan; 198(1):377-80. PubMed ID: 8259674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of different DNA vaccines for protection of experimental influenza A virus infection.
    Wiesener N; Schütze T; Lapp S; Lehmann M; Jarasch-Althof N; Wutzler P; Henke A
    Viral Immunol; 2011 Aug; 24(4):321-30. PubMed ID: 21830903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses.
    Altstein AD; Gitelman AK; Smirnov YA; Piskareva LM; Zakharova LG; Pashvykina GV; Shmarov MM; Zhirnov OP; Varich NP; Ilyinskii PO; Shneider AM
    Arch Virol; 2006 May; 151(5):921-31. PubMed ID: 16292596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A protective immune response in mice to viral components other than hemagglutinin in a live influenza A virus vaccine model.
    Horimoto T; Takada A; Iwatsuki-Horimoto K; Kawaoka Y
    Vaccine; 2004 Jun; 22(17-18):2244-7. PubMed ID: 15149783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective RNAs inhibit the assembly of influenza virus genome segments in a segment-specific manner.
    Duhaut SD; McCauley JW
    Virology; 1996 Feb; 216(2):326-37. PubMed ID: 8607262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.